Patent holdings for IPC class G01N 30/50

Total number of patents in this class: 109

10-year publication summary

5
9
6
7
5
11
6
3
12
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Shimadzu Corporation
6276
6
Regeneron Pharmaceuticals, Inc.
4510
6
Waters Technologies Corporation
1758
6
GE Healthcare Bio-Sciences AB
526
4
Cytiva Sweden AB
774
4
Bristol-myers Squibb Company
4809
3
JSR Corporation
2548
3
Bio-Rad Laboratories, Inc.
1615
3
Quest Diagnostics Investments LLC
425
3
Repligen Corporation
293
3
Biotage AB
95
2
Genzyme Corporation
1317
2
Global Life Sciences Solutions USA LLC
520
2
Cytiva BioProcess R&D AB
313
2
F. Hoffmann-La Roche AG
7881
1
Hoffmann-La Roche Inc.
3603
1
ExxonMobil Research And Engineering Company
2498
1
EMD Millipore Corporation
639
1
Merck Patent GmbH
5726
1
Centre National de La Recherche Scientifique
10802
1
Other owners 54